We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
-27.56%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$1.77B
AUM Growth
-$1.21B
Cap. Flow
-$436M
Cap. Flow %
-24.67%
Top 10 Hldgs %
12.3%
Holding
1,254
New
453
Increased
136
Reduced
157
Closed
433

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$28.3M
2
TW icon
Tradeweb Markets
TW
+$11.9M
3
QURE icon
uniQure
QURE
+$10.5M
4
ON icon
ON Semiconductor
ON
+$7.63M
5
INST
Instructure, Inc.
INST
+$7.04M

Sector Composition

Rank Sector Weight
1 Healthcare 4.85%
2 Consumer Discretionary 4.41%
3 Technology 1.8%
4 Industrials 1.5%
5 Energy 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAC icon
501
PUT
Macerich
MAC
$7.33B
$619K 0.04%
+110,000
New +$2.19M
ZGNX
502
PUT
DELISTED
Zogenix, Inc.
ZGNX
$619K 0.04%
+25,000
New +$910K
XRX icon
503
Xerox
XRX
$387M
$616K 0.03%
32,500
+28,250
+665% +$897K
EIDX
504
CALL
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$612K 0.03%
12,500
+2,500
+25% +$127K
EIDX
505
PUT
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$612K 0.03%
12,500
+2,500
+25% +$127K
DCP
506
PUT
DELISTED
DCP Midstream, LP
DCP
$611K 0.03%
+150,000
New +$2.5M
GOSS icon
507
PUT
Gossamer Bio
GOSS
$82.9M
$610K 0.03%
60,000
+30,000
+100% +$392K
NGL icon
508
PUT
NGL Energy Partners
NGL
$2.05B
$596K 0.03%
+229,300
New +$1.86M
NKTR icon
509
CALL
Nektar Therapeutics
NKTR
$2.39B
$588K 0.03%
2,200
-467
-18% -$144K
NKTR icon
510
PUT
Nektar Therapeutics
NKTR
$2.39B
$588K 0.03%
2,200
-467
-18% -$144K
GT icon
511
PUT
Goodyear
GT
$2B
$582K 0.03%
100,000
ZYME icon
512
CALL
Zymeworks
ZYME
$1.61B
$581K 0.03%
+16,400
New +$671K
NXST icon
513
PUT
Nexstar Media Group
NXST
$5.82B
$578K 0.03%
+10,000
New +$1.06M
GPRO icon
514
PUT
GoPro
GPRO
$130M
$576K 0.03%
220,000
HUN icon
515
CALL
Huntsman Corp
HUN
$1.71B
$575K 0.03%
39,900
-40,200
-50% -$784K
HUN icon
516
PUT
Huntsman Corp
HUN
$1.71B
$575K 0.03%
+39,900
New +$778K
SAGE
517
CALL
DELISTED
Sage Therapeutics
SAGE
$574K 0.03%
20,000
-37,700
-65% -$2.18M
DAL icon
518
Delta Air Lines
DAL
$57.5B
$570K 0.03%
+20,000
New +$991K
CYH icon
519
Community Health Systems
CYH
$393M
$568K 0.03%
+170,000
New +$689K
SBGI icon
520
Sinclair Inc
SBGI
$992M
$563K 0.03%
35,000
+10,000
+40% +$260K
UEIC icon
521
CALL
Universal Electronics
UEIC
$57.8M
$558K 0.03%
+14,500
New +$657K
UEIC icon
522
PUT
Universal Electronics
UEIC
$57.8M
$558K 0.03%
+14,500
New +$657K
DCP
523
DELISTED
DCP Midstream, LP
DCP
$556K 0.03%
+136,505
New +$2.27M
CONE
524
CALL
DELISTED
CyrusOne Inc Common Stock
CONE
$556K 0.03%
+9,000
New +$550K
ZD icon
525
Ziff Davis
ZD
$1.96B
$554K 0.03%
+8,510
New +$665K

Similar funds

Caption Management's Q1 2020 Portfolio in Review

As of Q1 2020, Caption Management held 1,254 positions worth $1.77B, down 41% from $2.98B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Caption Management withdrew a net $436M in Q1 2020, closing 433 positions and reducing 157 holdings. Its most notable exit was Medicines Co, an estimated $28.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 4.9% of assets, down from 5.7% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Caption Management opened a new position in Wayfair worth $7.62M.

  • Caption Management's largest Q1 2020 buy was Wayfair: 142,544 shares worth $7.62M.
  • Caption Management added most to GE Aerospace in Q1 2020, an estimated $8.43M increase.
  • Caption Management's biggest Q1 2020 reduction was uniQure, cutting an estimated $10.5M.
  • Caption Management fully exited Medicines Co in Q1 2020, selling an estimated $28.3M.
  • Caption Management's ten largest holdings make up 12% of its $1.77B portfolio in Q1 2020.
  • Caption Management opened 453 new positions and closed 433 in Q1 2020.
  • Caption Management's portfolio value fell 41% quarter-over-quarter to $1.77B.

Based on Caption Management's 13F filing for Q1 2020, filed 15 May 2020.